Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria

Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria

US Patent 11242339 · Granted Feb 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and materials for increasing level of phosphorylated AMPK protein2025
Methods and materials for increasing level of phosphorylated AMPK protein2025
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and a2025
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and a2025
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and a2025
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and a2025
Methods and materials for increasing transcription factor eb polypeptide levels2025
Methods and materials for increasing transcription factor eb polypeptide levels2025
Benzathine analogs2024
Benzathine analogs2024
Small molecule AMPK activators2023
Small molecule AMPK activators2023